$MBLY

Mobileye Global 3Q 2026: Revenue $492M, Net income ($67M), EPS ($0.08) — 10-Q Summary

Mobileye Global reported 3Q 2026 revenue of $492M, down 2.4% YoY, with a net loss of $67M, improved from $96M last year. Nine-month revenue rose 8% to $1.56B, driven by higher EyeQ and SuperVision shipments. The company expanded deployments and acquired Mentee Robotics.

Original reporting
Published Oct 29, 2026, 8:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Mobileye Global 3Q 2026: Revenue $492M, Net income ($67M), EPS ($0.08) — 10-Q Summary — source image
Decision brief

The 30-second read

$MBLYNeutralMed
01

Why it matters

Traders can use the reported revenue decline and improved net loss to update near-term earnings expectations, while the operational notes (EyeQ6 progress, SuperVision volume growth, TSMC supplier addition, and robotaxi/robotics plans) inform longer-horizon sentiment.

02

Market read

This is a company-specific quarterly disclosure with concrete financial datapoints and a few operational catalysts, but no explicit forward guidance or deal headline.

03

What to watch

The summary notes EyeQ and SuperVision shipment strength over nine months but does not quantify quarterly guidance, backlog, or margin drivers, which are key for trading beyond the headline EPS and net loss.

Relevance 7/10Novelty 6/10Timing: after-hours/filing day, based on the Oct. 29, 2026 10-Q summary

Background

The piece is an AI summary of Mobileye’s 10-Q filed Oct. 29, 2026, covering 3Q 2026 financials and selected business highlights.

Company-level read

Ticker impact

$MBLYNeutralMedium confidence
Context

Mobileye reported 3Q 2026 revenue of $492M (down 2.4% YoY) and narrowed net loss to ($67M), plus business updates on EyeQ6 and SuperVision.

Expected impact

Likely mixed reaction, with downside risk from the YoY revenue decline offset by loss narrowing and ongoing product/supplier progress.

Evidence & confidence

The article provides the company’s own quarterly financials and several forward-looking operational items, but it is a brief 10-Q summary without explicit guidance or a surprise catalyst beyond the reported quarter.

Market effects

ADAS and automotive-systems investors may reassess near-term demand and pricing pressure signals from Mobileye’s China mix shift.

China-related pricing/mix dynamics are highlighted via lower-priced China sales affecting average system prices.

Supplier diversification (TSMC added) and robotaxi/robotics plans may influence broader autonomous-driving supply-chain sentiment.

Counterpoint

The revenue decline and China mix headwind could outweigh the loss narrowing, implying margins may be improving only because of cost actions rather than accelerating demand.

Key entities

  • Mobileye Global Inc.

    Reported 3Q 2026 revenue of $492M and narrowed net loss to ($67M), with updates on EyeQ6, SuperVision, and supplier diversification.

  • Mentee Robotics

    Humanoid robotics company acquired by Mobileye in February 2026, referenced in the robotaxi/robotics plan.

  • TSMC

    Added as a supplier to diversify Mobileye’s manufacturing, per the business highlights.

Related articles

$MBLYMed

Piper Sandler reiterates Mobileye stock rating at overweight

Piper Sandler maintained an Overweight rating and $12.00 price target for Mobileye (MBLY) after its Q3 results beat expectations. The company's 2026 guidance increased but less than anticipated. Mobileye's stock is down 51% year-over-year, trading at $6.41. Piper Sandler noted risks like Chinese competition but expects higher-value ADAS sales to benefit Mobileye's P&L starting 2027. TD Cowen downgraded MBLY to Hold with a $7.00 price target, citing delays and partner challenges.

$MBLYMed

TD Cowen downgrades Mobileye stock rating on delayed timelines

TD Cowen downgraded Mobileye (MBLY) to Hold from Buy, lowering its price target to $7.00. The firm cited delayed timelines and headwinds with Western partners. Mobileye's Q3 2026 earnings missed expectations, with adjusted EPS of $0.11 and revenue of $492 million, down 2% YoY. The stock is near its 52-week low of $6.37, down 50% over the past year.

$MBLYMed

Mobileye Global Inc. Q3 2026 Earnings Call Summary

Mobileye Global Inc. raised its 2026 revenue guidance to $2.008 billion, citing higher SuperVision deliveries. The company is transitioning to comprehensive ADAS systems and expects EyeQ ASPs to stabilize in 2027. Q3 saw $51 million in R&D incentives boosting margins to 18%. Management confirmed on-track production programs with Volkswagen and plans for 2027 robotaxi commercialization.

$MBLYMedAI 8/10

Mobileye Global Q3 Earnings Call Highlights

Mobileye (MBLY) raised its 2023 revenue outlook to $2.008B and adjusted operating income to $400M, citing strong SuperVision deliveries. Q3 adjusted operating margin was 18%, up 3% YoY. The company expects 4.5M chips to be delivered to China by 2026 and sees growth in ADAS adoption.